Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.650
-0.045 (-1.67%)
At close: Jun 25, 2025, 4:00 PM
2.630
-0.020 (-0.75%)
After-hours: Jun 25, 2025, 4:20 PM EDT
Pulmonx Market Cap
Pulmonx has a market cap or net worth of $105.88 million as of June 25, 2025. Its market cap has decreased by -61.47% in one year.
Market Cap
105.88M
Enterprise Value
74.12M
1-Year Change
-61.47%
Ranking
Category
Stock Price
$2.65
Market Cap Chart
Since the IPO on October 1, 2020, Pulmonx's market cap has decreased from $1.33B to $105.88M, a decrease of -92.06%. That is a compound annual growth rate of -41.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2025 | 108.49M | -59.54% |
| Dec 31, 2024 | 268.12M | -45.11% |
| Dec 29, 2023 | 488.43M | 54.88% |
| Dec 30, 2022 | 315.36M | -73.31% |
| Dec 31, 2021 | 1.18B | -52.01% |
| Dec 31, 2020 | 2.46B | 84.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 689.53B |
| Johnson & Johnson | 362.33B |
| Novo Nordisk | 326.28B |
| AbbVie | 324.13B |
| UnitedHealth Group | 271.37B |
| Abbott Laboratories | 230.56B |
| Novartis AG | 229.25B |
| AstraZeneca | 217.06B |